Sign in

NCT03959839Completed

Endoscopic Submucosal Dissection vs Local Laparoscopic Surgical Resection (TAMIS/TEO) in Early Rectal Neoplasias

Endoscopic Submucosal Dissection Versus Local Laparoscopic Surgical Resection (Transanal Minimally Invasive Surgery [TAMIS] / Transanal Endoscopic Operation [TEO]) In Early Rectal Neoplasias. Multicentric and Randomized Clinical Trial

Source: ClinicalTrials.gov · Last updated 3 Jun 2025

Brief summary (registry, in English)

A multicenter non-inferiority randomized clinical trial to compare Endoscopic treatment (ESD) and Minimally Invasive Laparoscopic Local Surgical Treatment (TAMIS or TEO) for early rectal neoplastic lesions (adenoma \& T1CRC) Primary aim: To compare the long-term local recurrence rate (12 months after the procedure) Secondary aims: Compare en-bloq resection rate, R0 resection, time per procedure, short-term recurrence rate, safety (rate of complications), morbidity and cost-effectiveness analyses.

Status (registry)
Completed
Study type
Interventional
Enrollment
70 (actual)
First submitted
16 May 2019
Start date
1 Apr 2019
Primary completion date
20 Dec 2024
Lead sponsor
Dr. Alberto Herreros de Tejada Echanojáuregui
NCT number
NCT03959839

What you commit to

  • Study type: Interventional
  • Participants enrolled: 70
  • From 1 Apr 2019 to the primary completion date, 20 Dec 2024
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Anorectal fibrosis due to previous anorectal surgery.
  • Existence of synchronous colorectal lesions that require other surgical treatment in any case.

Other illness

  • Diagnosis of inflammatory bowel disease with rectal involvement.

Other

  • Patients who refuse to participate.
  • Pregnant.
  • Lateral Spreading Lesions (LST classification) Granular Homogeneous type
  • Lesions greater than 50 mm when there is suspicion of advanced histology (Kudo Vi superficial pattern).
  • Rectal lesions of any size with high suspicion of deep submucosal invasion or locoregional lymph node involvement, either in the diagnostic colonoscopy (Kudo Vn pit pattern, NICE 3 pattern, Sano IIIB pattern) or by complementary imaging tests (rectal EUS/Pelvic MRI)

Who the study is looking for

  • Patients older than 18 y/o
  • Non-pedunculated rectal lesions (sessile 0-Is or flat 0-II) greater than 20 mm in diameter.
  • The edges of the lesion should be more than 3 cm from the external anal margin and up to 14 cm from it.
  • Circumferential involvement \<50%

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hospital de Sant Joan Despí - Moises Broggi
Coordinator of this site? Confirm its status
BarcelonaSpainUnknown status
Hospital General Universitario Gregorio Marañón
Coordinator of this site? Confirm its status
MadridSpainUnknown status
Hospital Universitario Puerta de Hierro
Coordinator of this site? Confirm its status
MajadahondaSpainUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.